TRIDENT LIFELINE
Back to Income Statement
|
TRIDENT LIFELINE Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Consolidated Net Profit | ₹12 Cr | ₹6.34 Cr | ₹6.02 Cr | ₹3.95 Cr |
What is the latest Consolidated Net Profit of TRIDENT LIFELINE ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹12 Cr |
| Mar2024 | ₹6.34 Cr |
| Mar2023 | ₹6.02 Cr |
| Mar2022 | ₹3.95 Cr |
How is Consolidated Net Profit of TRIDENT LIFELINE Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹12 Cr | 85.18 | |
| Mar2024 | ₹6.34 Cr | 5.47 | |
| Mar2023 | ₹6.02 Cr | 52.36 | |
| Mar2022 | ₹3.95 Cr | - | |
Compare Consolidated Net Profit of peers of TRIDENT LIFELINE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TRIDENT LIFELINE | ₹473.1 Cr | -4.7% | 7% | 33% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,831.0 Cr | -0.4% | -6.1% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹242,074.0 Cr | 0.9% | -3.3% | 39.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹175,355.0 Cr | 0.1% | -7.2% | 28.2% | Stock Analytics | |
| CIPLA | ₹107,439.0 Cr | -0.3% | -4% | -15.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,417.0 Cr | 1.5% | 3.1% | 0.4% | Stock Analytics | |
TRIDENT LIFELINE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TRIDENT LIFELINE | -4.7% |
7% |
33% |
| SENSEX | 0.6% |
-1.4% |
-10.7% |
You may also like the below Video Courses